rediff.com
e.g. Tata motors, Reliance MF, 500570
Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Sales 291.61 264.08 222.42 245.38 223.32
Operating profit 51.86 45.82 40.89 52.17 48.24
Interest 0.81 0.55 0.87 0.58 0.54
Gross profit 67.44 57.45 44.54 57.68 50.89
EPS (Rs) 23.30 19.33 14.29 20.13 17.59
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20
Other income 16.39 12.18 4.53 6.09 3.19
Stock adjustment 9.91 -4.31 -11.67 -1.84 6.18
Raw material 92.36 95.29 83.67 60.07 47.49
Power and fuel - - - - -
Employee expenses 51.41 45.98 34.35 30.21 24.72
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 86.06 81.30 75.19 104.77 96.70
Provisions made - - - - -
Depreciation 5.13 4.49 4.18 2.95 2.83
Taxation 15.65 14.23 11.74 14.47 12.88
Net profit / loss 46.67 38.72 28.63 40.26 35.19
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 20.03 20.03 20.03 20.00 20.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 17.79 17.35 18.38 21.26 21.60
GPM (%) 21.90 20.80 19.63 22.94 22.47
NPM (%) 15.15 14.02 12.61 16.01 15.53
Close
Add Lincoln Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Lincoln Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close